KRAS-RERGL Fusion FISH Probe
The KRAS-RERGL Fusion FISH Probe is used to confirm a fusion of the KRAS and RERGL genes. The fusion of the KRAS and RERGL genes has been associated with Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| KRAS-RERGL-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-RERE | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-REOR | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-REGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-REGR | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-OROR | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GORE | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GROR | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| KRAS-RERGL-20-AQAQ | 20 (40 μL) | 200 μL |
|
KRAS Gene Summary
This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
Gene Name: KRAS Proto-oncogene, GTPase
Chromosome: CHR12: 25358179 -25403854
Locus: 12p12.1
RERGL Gene Summary
The RERG Like (RERGL) gene is located on chr12 :18233802-18243114 at 12p12.3.
Gene Name: RERG Like
Chromosome: CHR12: 18233802 -18243114
Locus: 12p12.3
Gene Diseases
The KRAS RERGL Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|